DEMO SA: "We Bring the Future into the Present" The company announced its 2021-2027 investment plan, worth EUR 356 million.
Athens, November 9th 2021 On Tuesday, November 9, 2021, the CEO of the…
DEMO SA: Platinum, Gold and Bronze Award at the Healthcare Business Awards 2021
Athens, 22nd September 2021 Three awards were the result for DEMO SA at…
DEMO Corporate Social Responsibility Programme DEMO has allocated over €1 million to support the National Health System, NGOs and employees
Athens, 19 February 2021 For DEMO, successful entrepreneurship is not only the…
The pharmaceutical industry DEMO S.A stands with the people of Lebanon after the explosion in Beirut, in early August. Dispatching of large quantities of pharmaceutical supplies to all hospitals of the country
Athens, 25.8.2020 The Pharmaceutical Industry DEMO following the lethal…
Positive messages from the use of Dexamethasone for coping with Covid-19. In 2021, DEMO SA shall launch a Dexamethasone formulation in Greece.
Athens, July 15th, 2020 The DEMO Pharmaceutical Industry with 4 manufacturing…
Event for the New Year's cake organized by DEMO ABEE Turnover increase by 16 million euros in comparison to 2018 New Investment Plan of the company for the following 5 years
Athens, 4 February, 2020 With our wishes for a creative year, the…
DEMO SA wins Gold at the Manufacturing Excellence Awards 2019
Athens, October 15th, 2019 DEMO SA Pharmaceutical Industry received the Gold…
Event of cutting the New Year’s cake organized by DEMO S.A. Pharmaceutical Industry The company’s new Investment Plan for 2019-2022 of a total amount of 30 million Euros
Athens, February, 1 2019 DEMO S.A. Pharmaceutical Industry welcomed 2019,…
DEMO S.A. Pharmaceutical Industry Two Golden Awards in the DEVELOPMENT section at the “Healthcare Business Awards 2018”
DEMO S.A. Pharmaceutical Industry stood out with two Golden Awards in the…
Cutting the new year’ cake at DEMO S.A.
Cutting the new year’ cake at DEMO S.A. Investments in Buildings, Machinery,…